$BIIB Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $2.62 down -45.53% YoY
• Reported revenue of $2.8B up 10.63% YoY
• Biogen raised FY 2026 reported Non-GAAP diluted EPS guidance to $12.20 to $13.00 from $12.00 to $13.00; full-year revenue is expected to increase by a mid-single digit percentage.